Patents by Inventor Richard R. Wilson

Richard R. Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8538542
    Abstract: Systems and methods of using a system for treating a gastrointestinal disorder characterized by dysmotility of a gastrointestinal organ.
    Type: Grant
    Filed: July 21, 2011
    Date of Patent: September 17, 2013
    Assignee: EnteroMedics Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Patent number: 8483830
    Abstract: Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.
    Type: Grant
    Filed: April 3, 2009
    Date of Patent: July 9, 2013
    Assignee: EnteroMedics Inc.
    Inventors: Katherine S. Tweden, Mark B. Knudson, Richard R. Wilson, Arnold W. Thornton, Dennis Dong-won Kim
  • Patent number: 8369952
    Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning an electrode on a vagus nerve. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. In some embodiments, the disorder is gastroparesis. The signal may be a blocking or a stimulation signal. In some embodiments, the signal is selected to a) at least in part, upregulate neural activity on the vagus nerve without triggering muscular contractility, and, b) increase pancreobilliary output.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: February 5, 2013
    Assignee: EnteroMedics, Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Publication number: 20120253237
    Abstract: A method of delivery ultrasonic energy and a therapeutic compound to a treatment site and an ultrasonic catheter system are disclosed. The ultrasonic catheter system comprises a tubular body having a proximal end, a distal end and a treatment zone located between the distal end and the proximal end, a fluid delivery lumen, at least one ultrasound radiating element positioned in the treatment zone, wiring electrically coupled to the at least one ultrasound radiating element and extending through the tubular body and terminating at a connector, and a control system comprising external circuitry and an isolation pod that is configured to be electrically connected to the connector, the isolation pod being positioned between the tubular body and the external system and comprising an isolation barrier and circuitry for driving the ultrasound radiating element.
    Type: Application
    Filed: March 27, 2012
    Publication date: October 4, 2012
    Applicant: EKOS CORPORATION
    Inventors: Richard R. Wilson, Robert L. Wilcox, Curtis Genstler, Tim Abrahamson, Wm. Gerrit Barrere, Amy Cohen, George Keilman, Leonard R. Oliver, Natalya Peskin
  • Patent number: 8226629
    Abstract: A method of treating an occlusion at a treatment site within a patient's vasculature comprises providing an ultrasonic catheter. The ultrasonic catheter has a distal region, a proximal region opposite the distal region, a fluid delivery lumen having at least one opening in the distal region, and an ultrasound radiating member positioned within the distal region. The method further comprises positioning the ultrasonic catheter at the treatment site, such that at least a portion of the distal region is within the occlusion. The ultrasonic catheter further comprises passing a therapeutic compound through the fluid delivery lumen such that the therapeutic compound is delivered to the treatment site. The ultrasonic catheter further comprises emitting ultrasonic energy from the ultrasound radiating member. The emitted ultrasonic energy has an amplitude that is periodically varied between a low amplitude and a high amplitude.
    Type: Grant
    Filed: March 31, 2009
    Date of Patent: July 24, 2012
    Assignee: Ekos Corporation
    Inventors: George Keilman, Douglas R. Hansmann, Azita Soltani, Richard R. Wilson
  • Publication number: 20120130330
    Abstract: A stacked moisture sensing device and urinary continence monitoring system are disclosed. The stacked moisture sensing device has at least a first media-sensor arrangement adjacent to a second media-sensor arrangement. In one embodiment, each of the media-sensor arrangements has a media layer with a first face, a second face and a side edge that extends between the faces wherein the media layers have differing hydrophilicities. Embedded in each media layer is a moisture sensor which can be a wired type tensor or a wireless RFD type sensor. The stacked moisture sensing device can be used in a variety of applications, such as for use in urinary continence monitoring and for use in shipping containers. In urinary continence monitoring applications, a data collection unit can be provided to acquire data from the sensors, which are located in an absorbent undergarment. Methods for locating the sensors within the absorbent undergarment are also disclosed.
    Type: Application
    Filed: November 19, 2010
    Publication date: May 24, 2012
    Inventors: Richard R. Wilson, Douglas R. Oudekerk, Douglas P. Wilson, Karia M. Fogel, Rebecca Neth Townsend
  • Patent number: 8167831
    Abstract: A method of delivery ultrasonic energy and a therapeutic compound to a treatment site and an ultrasonic catheter system are disclosed. The method comprises providing a catheter with a plurality of ultrasound radiating members, wherein the plurality of ultrasound radiating members are allocated into electrical groups comprising more than one ultrasound radiating member. The method further comprises independently driving each group of ultrasonic radiating members, and delivering the therapeutic compound through the catheter to the treatment site.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: May 1, 2012
    Assignee: Ekos Corporation
    Inventors: Richard R. Wilson, Robert L. Wilcox, Curtis Genstler, Tim Abrahamson, Wm. Gerrit Barrere, Amy Cohen, George Keilman, Leonard R. Oliver, Natalya Peskin
  • Publication number: 20120041509
    Abstract: A method for treating at least one of a plurality of disorders characterized at least in part by vagal activity includes positioning an electrode around a body organ innervated by the vagus. An electrical signal is applied to the electrode to modulate vagal activity. The electrical signal is applied at a frequency selected for the signal to create a neural conduction block to the vagus with the neural conduction block selected to at least partially block nerve impulses on the vagus. The application of the electrical signal is discontinued. The application of the signal and the discontinuing of the signal are repeated with durations of the discontinuing and the application selected to treat the disorder.
    Type: Application
    Filed: October 19, 2011
    Publication date: February 16, 2012
    Applicant: EnteroMedics Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Publication number: 20120035509
    Abstract: Systems and methods for analyzing the gait of an individual are disclosed. The disclosed systems and methods can be configured to acquire data from a first array and a second array of sensors that are configured to be placed in a left and/or right shoe, respectively. The acquired data can be collected or separated into at least two separate gait phases for each array, compared to a baseline condition for each gait phase and categorized into one of at least two uniformity categories for each gait phase. Examples of collected and/or calculated data include pressure values, shear stress values and torque values. The analysis can be focused on both feet of a person, or focused on one foot. A graphical output showing at least one entire gait cycle based on the uniformity categories can then be generated.
    Type: Application
    Filed: August 6, 2010
    Publication date: February 9, 2012
    Inventors: Richard R. Wilson, Douglas R. Oudekerk, Douglas P. Wilson, Karla M. Fogel, Rebecca Neth Townsend
  • Publication number: 20110282411
    Abstract: At least one of a plurality of gastrointestinal disorders is treated by stimulating an enteric nervous system of a patient to enhance a functional tone of the enteric nervous system. A treatment includes electrically stimulating a vagus nerve of the patient at a stimulation site proximal to at least one site of vagal innervation of a gastrointestinal organ. The electrical stimulation includes applying a stimulation signal at the stimulation site. An optional proximal electrical blocking signal is applied to the vagus nerve at a proximal blocking site proximal to the stimulation site. The proximal blocking signal is selected to at least partially block nerve impulses at the proximal blocking site.
    Type: Application
    Filed: July 21, 2011
    Publication date: November 17, 2011
    Applicant: EnteroMedics Inc
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Publication number: 20110270344
    Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning an electrode on a vagus nerve. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. In some embodiments, the disorder is bulimia. The signal may be a blocking or a stimulation signal. In some embodiments, the signal is selected to, at least in part, downregulate neural activity on the vagus nerve.
    Type: Application
    Filed: July 7, 2011
    Publication date: November 3, 2011
    Applicant: EnteroMedics Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Patent number: 8046085
    Abstract: A method for treating at least one of a plurality of disorders characterized at least in part by vagal activity includes positioning an electrode around a body organ innervated by the vagus. An electrical signal is applied to the electrode to modulate vagal activity. The electrical signal is applied at a frequency selected for the signal to create a neural conduction block to the vagus with the neural conduction block selected to at least partially block nerve impulses on the vagus. The application of the electrical signal is discontinued. The application of the signal and the discontinuing of the signal are repeated with durations of the discontinuing and the application selected to treat the disorder.
    Type: Grant
    Filed: October 20, 2010
    Date of Patent: October 25, 2011
    Assignee: EnteroMedics Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Patent number: 8010204
    Abstract: A system comprising: at least one electrode adapted to be placed on a vagus nerve below a vagal innervation of the heart; an implantable controller comprising an induction coil, at least one circuit for generating a neural conduction blocking signal connected to the at least one electrode, a battery, and a central processing unit comprising program storage and memory; and an external programmer configured to: communicate at least one parameter for the neural conduction blocking signal to the implantable controller, wherein the parameter is selected for the neural conduction blocking signal to i) at least partially downregulate the vagus nerve, ii) allow at least partial recovery of the nerve activity following discontinuation of the neural conduction blocking signal, and iii) reduce pancreatic and biliary output via inhibition of pancreo-biliary output; and an external coil adapted to be worn by the patient, wherein the external coil is connected to the external programmer, and is adapted to inductively coupl
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: August 30, 2011
    Assignee: EnteroMedics Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Patent number: 7986995
    Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning an electrode on a vagus nerve. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. In some embodiments, the disorder is bulimia. The signal may be a blocking or a stimulation signal. In some embodiments, the signal is selected to, at least in part, downregulate neural activity on the vagus nerve.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: July 26, 2011
    Assignee: EnteroMedics Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Patent number: 7967758
    Abstract: Devices and methods for detecting inadequate tissue perfusion by measuring a parameter other than heart rate such as vascular blood pressure, intracardiac blood pressure, vascular blood flow or tissue perfusion, in addition to or as a substitute for heart rate. Such devices and methods improve the accuracy of determining when and to what degree therapy should be administered to treat inadequate tissue perfusion, such as pre-syncope, syncope, or orthostatic hypotension, particularly in the absence of abnormal cardiac function.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: June 28, 2011
    Assignee: Data Sciences International, Inc.
    Inventors: David G. Benditt, Brian P. Brockway, Richard R. Wilson
  • Publication number: 20110060253
    Abstract: A catheter system for delivering ultrasonic energy to a treatment site within a body lumen comprises a tubular body. The tubular body has a proximal end, a distal end and an energy delivery section positioned between the proximal end and the distal end. The catheter further comprises an inner core configured for insertion into the tubular body. The inner core comprises a first ultrasound radiating member axially separated from a second ultrasound radiating member by an intermediate flexible joint region. The inner core further comprises an electrically conductive portion configured to allow a voltage difference to be applied to at least one of the ultrasound radiating members. The inner core further comprises a high impedance cap positioned proximal to at least one of the ultrasound radiating members.
    Type: Application
    Filed: July 6, 2010
    Publication date: March 10, 2011
    Applicant: EKOS CORPORATION
    Inventor: RICHARD R. WILSON
  • Publication number: 20110034968
    Abstract: A method for treating at least one of a plurality of disorders characterized at least in part by vagal activity includes positioning an electrode around a body organ innervated by the vagus. An electrical signal is applied to the electrode to modulate vagal activity. The electrical signal is applied at a frequency selected for the signal to create a neural conduction block to the vagus with the neural conduction block selected to at least partially block nerve impulses on the vagus. The application of the electrical signal is discontinued. The application of the signal and the discontinuing of the signal are repeated with durations of the discontinuing and the application selected to treat the disorder.
    Type: Application
    Filed: October 20, 2010
    Publication date: February 10, 2011
    Applicant: EnteroMedics Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Publication number: 20100331763
    Abstract: An ultrasound catheter comprises an elongate tubular body is disclosed. The elongate tubular body has a proximal region and a distal region opposite the proximal region. The tubular body defines a central lumen having a central lumen surface that is electrically conductive. The ultrasound catheter further comprises an elongate, hollow inner core extending through the central lumen and has an inner core outer surface that is electrically conductive. The ultrasound catheter further comprises an ultrasound radiating member positioned within the distal region of the tubular body and between the tubular body and the inner core, such that the tubular body conductive surface and the inner core conductive surface are both in electrical contact with the ultrasound radiating member. The ultrasound catheter further comprises an insulating sleeve positioned between the tubular body and the inner core in a region proximal to the ultrasound radiating member.
    Type: Application
    Filed: July 29, 2010
    Publication date: December 30, 2010
    Applicant: EKOS CORPORATION
    Inventors: RICHARD R. WILSON, TIM ABRAHAMSON, LEONARD R. OLIVER
  • Patent number: 7844338
    Abstract: A method for treating at least one of a plurality of disorders characterized at least in part by vagal activity includes positioning an electrode around a body organ innervated by the vagus. An electrical signal is applied to the electrode to modulate vagal activity. The electrical signal is applied at a frequency selected for the signal to create a neural conduction block to the vagus with the neural conduction block selected to at least partially block nerve impulses on the vagus. The application of the electrical signal is discontinued. The application of the signal and the discontinuing of the signal are repeated with durations of the discontinuing and the application selected to treat the disorder.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: November 30, 2010
    Assignee: EnteroMedics Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Patent number: 7828762
    Abstract: A catheter for delivering ultrasonic energy and therapeutic compounds to a treatment site within a patient's vasculature comprises a tubular body. The tubular body has a proximal region and a distal region opposite the proximal region. The catheter further comprises a plurality of fluid delivery lumens formed into the tubular body. The catheter further comprises an inner core configured for insertion into the tubular body. The inner core comprises an elongate electrical conductor having a plurality of flattened regions, each flattened region having a first flat side and a second flat side opposite the first flat side. The inner core further comprises a plurality of ultrasound radiating members mounted in pairs to the flattened regions of the elongate electrical conductor. A first ultrasound radiating member is mounted to the first flat side of the elongate electrical conductor, and a second ultrasound radiating member is mounted to the second flat side of the elongate electrical conductor.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: November 9, 2010
    Assignee: Ekos Corporation
    Inventors: Richard R. Wilson, Robert L. Wilcox, Curtis Genstler, Tim Abrahamson, Wm. Gerrit Barrere, Amy Cohen, George Keilman, Leonard R. Oliver, Natalya Peskin